Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Convertible Debt Current Assets Current Deferred Revenue Current Leases Current Taxes Dividends payables Finished Goods Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Abvc Biopharma (ABVC) Raw Materials (2018 - 2019)

Historic Raw Materials for Abvc Biopharma (ABVC) over the last 2 years, with Q4 2019 value amounting to $57904.0.

Abvc Biopharma's Raw Materials rose 213.97% to $57904.0 in Q4 2019 from the same period last year, while for Dec 2019 it was $57904.0, marking a year-over-year increase of 213.97%. This contributed to the annual value of $57904.0 for FY2019, which is 213.97% up from last year.
According to the latest figures from Q4 2019, Abvc Biopharma's Raw Materials is $57904.0, which was up 213.97% from $55835.0 recorded in Q3 2019.
Abvc Biopharma's Raw Materials' 5-year high stood at $57904.0 during Q4 2019, with a 5-year trough of $55824.0 in Q2 2019.